Extended Data Fig. 9: Measurement of hydrogen sulfide in fecal samples.
From: Synergy and oxygen adaptation for development of next-generation probiotics
Hydrogen sulfide was measured in fecal samples at baseline as well as at the end of the administration (40 individuals: placebo, n = 12; low dose, n = 16; high dose, n = 12; no sufficient material available for 1 individual in the placebo and 2 in the high dose groups). Two-sided Wilcoxon signed-rank test was performed. Data are presented as mean ± s.e.m.
